A new registry analysis suggests transcatheter aortic valve replacement (TAVR) may benefit patients with severe aortic stenosis but only minimal symptoms.
The US Food and Drug Administration has only approved TAVR devices to treat severe, symptomatic aortic stenosis, but about 20% of the TAVR patients in TVT Registry had severe...